20. 副腎白質ジストロフィー Adrenoleukodystrophy Clinical trials / Disease details

臨床試験数 : 61 / 薬物数 : 90 - (DrugBank : 31) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 126

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02961803 (ClinicalTrials.gov)	October 2014	9/11/2016	MD1003-AMN MD1003 in Adrenomyeloneuropathy	MD1003 in Adrenomyeloneuropathy : a Randomized Double Blind Placebo Controlled Study	Adrenomyeloneuropathy;Adrenoleukodystrophy;AMN	Drug: MD1003 100 mg capsule;Drug: Placebo	MedDay Pharmaceuticals SA	NULL	Completed	18 Years	60 Years	Male	67	Phase 2/Phase 3	France;Germany;Spain
2	EUCTR2014-000698-38-ES (EUCTR)	13/08/2014	13/06/2014	MD1003 IN ADRENOMYELONEUROPATHY	MD1003 IN ADRENOMYELONEUROPATHY: A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY - MD1003-AMN	Adrenomyeloneuropathy MedDRA version: 17.0;Level: LLT;Classification code 10069075;Term: Adrenomyelo ...	Product Name: biotin Product Code: MD1003 INN or Proposed INN: D-BIOTIN	MEDDAY SAS	NULL	Not Recruiting			Female: no Male: yes	60	Phase 2;Phase 3	Spain

First Previous1Next Last